coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Hastings & St Leonards PCN, Hastings · Health Inequalities Profile

    PCN U99438 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 8 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    100,887

    Registered population

    59.8% aged 18–64

    21.6%

    Aged 65+

    ICB 21.9% · England 17.9%

    8.3%

    Ethnic minority (non-White)

    2.7% Asian · England 9.6%

    47.7%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    ~39,671

    Core20 residents (est.)

    Resident basis; registered basis ~48,556 · see page 3

    17,634

    Hypertension register

    +8.46% in 3 yrs · England +5.60%

    1,684

    SMI register

    100% of Hastings'

    3,264

    COPD register

    Reviews +8.08% in 3 yrs

    Forecast to 2030

    21,154

    Hypertension patients, 2030

    +3,520 on today

    73.6%

    QRISK ≥20% on statins, 2030

    +5.76pp over 3 yrs

    6.1%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    60.2%
    Asthma annual reviews fell while England rose.

    Coverage is 60.2% (England 65.7%) after changing by -4.3% over 2023 to 2025 (England +4.4%), leaving about 2,600 patients unreviewed, which may reflect recall.

    83.1%
    Early MMR uptake trails the 95% target.

    In Q1 2025/26, 24-month MMR dose 1 coverage is 83.1% (England 88.3%, -11.9 pp to the 95% target), alongside a 6 pp age-five dose.

    +7.5%
    Primary prevention statin prescribing outpaced national growth.

    Statin treatment in diabetes without CVD grew +7.5% over 2023 to 2025 (England +2.1%), reaching 76.1% against 73.2% in England.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Over a fifth of patients are aged 65+, exceeding England by 3.7 percentage points

    Across 100,887 registered patients, 21.6% (21,789) are aged 65+, compared with 19.8% in Hastings, 21.9% in NHS Sussex Integrated Care Board and 17.9% in England. Registered patients aged 18-64 represent 59.8% (60,314) and aged 0-17 represent 18.6% (18,784). Ethnicity data reflect Census usual residents, not registered patients: 91.7% are White against 91.4% in Hastings, 91.0% in NHS Sussex Integrated Care Board and 81.1% in England, giving an 8.3% ethnic minority share. Projected list growth to 2030 is 1.0% (Hastings 1.0%, NHS Sussex Integrated Care Board 2.1%, England 2.3%), with unverified projection methodology.

    Age profile

    0–1718.6%
    18–6459.8%
    65+21.6%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White91.7%
    Mixed2.8%
    Asian2.7%
    Other1.4%
    Black1.4%

    Older people · falls rows are Hastings local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Hastings LA)2,4942,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)81.8%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.3%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Hastings LA)1,2369819552024/25
    Falls deaths, all ages, per 100,000 (Hastings LA)10.614.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 share reaches 47.7%, spanning 51.0 pp between practices across the PCN

    Across the PCN, 47.7% of registered patients live in Core20 areas, compared with 49.5% in Hastings, 9.2% in NHS Sussex Integrated Care Board, and 21.0% in England. Practice share spans 51.0 pp, from 26.2% at The Hill Surgery to 77.2% at Priory Road Surgery, though Hastings Old Town Surgery holds the highest volume (14,904 estimated patients). Denominators must be reconciled before targeting: practice estimates sum to 48,556 registered patients, whereas the resident estimate for deciles 1 and 2 is 39,671.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Priory Road77.2% · 2,968 patients
    Station61.1% · 10,793 patients
    Hastings Old Town58.7% · 14,904 patients
    Carisbrooke53.1% · 4,503 patients
    South Saxon House41.4% · 1,423 patients
    High Glades39.6% · 7,668 patients
    Sedlescombe House38.5% · 1,116 patients
    Hill26.2% · 5,181 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    1,684

    SMI register

    1.66% recorded prevalence

    905

    Learning disability register

    0.89% recorded prevalence

    65

    Care homes, 1,541 beds

    In the PCN catchment

    9.9%

    Provide unpaid care

    Hastings, Census 2021

    Severe mental illness prevalence is 1.7% (1,684 patients; Hastings 1.7%, NHS Sussex Integrated Care Board 1.1%, England 1.0%) and learning disability is 0.9% (905 patients; England 0.6%). Catchment data show 65 care homes (1,541 beds); borough homelessness (37 rough sleepers) and carer ceiling estimates (about 10,000) are local authority figures. Higher recorded SMI and learning disability prevalence than England suggests proactive annual reviews and care-home coordination as potential inclusion priorities.

    Severe mental illness: physical health checks

    Severe mental illness prevalence is 1.7% (England 1.0%). Recorded blood pressure checks reached 80.4% (England 83.4%) and BMI checks reached 78.0% (England 82.1%). Metabolic monitoring trailing England benchmarks may indicate recall gaps to test through practice audits.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    17,634

    Hypertension register

    +8.46%

    Register growth, 3 yrs

    Hastings +6.16% · England +5.60%

    +3.98pp

    BP control, under 80

    ≤140/90 · +0.70pp aged 80+

    +3,520

    More patients by 2030

    Forecast 21,154 (20.45%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 17.4% (17,634 patients), above England (15.2%) and NHS Sussex Integrated Care Board (16.3%), with three-year growth of +8.5% (England +5.6%). However, blood pressure control for patients aged 80 and over is 77.1%, trailing England (81.2%) and NHS Sussex Integrated Care Board (79.2%). For patients under 80, control reaches 66.4% (England 67.8%). Crude prevalence is unadjusted for age. Lower blood pressure control among older patients could reflect medication review gaps, testable via clinical audit.

    Lipids and statins

    Patients with QRISK ≥ 20% receiving lipid-lowering therapy reach 60.2%, below England (63.6%) though in line with NHS Sussex Integrated Care Board (60.0%). Secondary prevention in diabetes reaches 81.3% (England 84.4%). Lower coverage than England may indicate treatment recall gaps to test through clinical audit.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026220,234£1.90£2.42£1.86£418,445
    Cardiovascular (all), 2025277,365£2.97£3.32£3.33£823,774

    In 2026, 220,234 items of lipid-regulating drugs were prescribed at £1.90 per item (spend £418,445; England £1.86, NHS Sussex Integrated Care Board £2.42). The PCN spent £8,809 more than at England's unit cost, but £114,522 less than at the ICB unit cost. Unit-cost differences could reflect formulary choices to test via prescribing review.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −4.31%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +4.36%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 6.8% (England 6.6%), but reviews fell 4.3% over 2023 to 2025 (England +4.4%) to 60.2% (England 65.7%), leaving about 2,600 patients on the 6,554 register unreviewed. For ages 6–19, second-hand smoke recording is 69.3% (England 78.8%), with 2,214 asthma items prescribed per 1,000 population aged 5–19 (England 1,488). COPD prevalence is 3.2% (England 1.9%) with reviews rising +8.1% (England +2.8%) to 74.6% (England 76.4%). Trailing reviews may indicate recall gaps to test through practice audits.

    Cancer register and children's immunisation

    Cancer prevalence is 4.6% (4,624 patients; England 3.8%). In Q1 2025/26, MMR1 coverage at 24 months is 83.1%, falling below the 95.0% target by 11.9 pp (England 88.3%). At age 5, MMR1 coverage reaches 92.1% while MMR2 drops to 86.1%, showing a 6 pp dose gap. Coverage below targets may reflect call-recall delays, testable through practice audits.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months92.2%

    England 91.0%

    6-in-1 complete primary course at 24 months88.1%

    England 92.2%

    MMR dose 1 at 24 months83.1%

    England 88.3%

    MMR dose 2 at age 586.1%

    England 82.8%

    4-in-1 pre-school booster at age 586.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    In 2022, 58.5% of staged cancers across NHS Sussex ICB were diagnosed at stage 1 or 2 (4,799 of 8,209 known-stage cases; England 55.3%), sitting 16.5 pp below the 75.0% national ambition. Known-stage completeness was 64.3% (8,209 of 12,766 registered cases; England 67.0%). About 1,360 additional early-stage diagnoses a year are needed across the ICB to reach 75%. Within the PCN, cervical screening (25-49 yrs) is 66.3% (NHS Sussex Integrated Care Board 68.6%), with The Station Practice at 60.6% and Hastings Old Town Surgery at 63.0%. Prioritising screening uptake in lower-coverage practices may help identify earlier lesions and support broader system diagnosis ambitions.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    At East Sussex Healthcare NHS Trust, cancer 62-day referral to treatment was 18.0 pp below the 85.0% standard (67.0418%). The trust met the 28-day faster diagnosis standard at 84.1975% (9.2 pp above the 75.0% standard) and 31-day combined treatment at 98.1873% (2.2 pp above the 96.0% standard). Across NHS Surrey and Sussex Integrated Care Board, 62-day referral to treatment was 13.5 pp below the 85.0% standard (71.5074%), 28-day faster diagnosis was 79.2873% (4.3 pp above 75.0%) and 31-day treatment was 90.4462% (5.6 pp below 96.0%). These secondary care metrics describe wider system performance.

    Pathways within standard (%)East Sussex HealthcareMaidstone and Tunbridge WellsEast KentSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)84.2081.7871.2879.2979.32
    31-day treatment (96%)98.1998.3596.6790.4592.50
    62-day referral to treatment (85%)67.0487.4370.0171.5171.16
    Diagnostic waits over 6 weeks (%)East Sussex HealthcareMaidstone and Tunbridge WellsEast KentEngland
    MRI6.480.9247.5821.40
    CT0.480.5137.459.92
    Echocardiography21.942.5714.1728.48
    Colonoscopy0.7419.809.5830.83
    Gastroscopy0.3124.0322.1629.02
    All 15 DM01 tests5.276.4248.3823.14
    Community services activityEast Sussex residentsSurrey and Sussex ICB
    Care contacts100,740309,615
    Referrals17,28566,930
    Patients with a contact25,88085,660

    Community services (residents of East Sussex), Jun 2026 (provisional). In provisional Jun 2026 Community Services Data Set records, 68% of community contacts for Hastings borough residents were with adults aged 65+ (68,465 of 100,740 contacts). No community provider was captured. Borough-level community contacts describe local system activity outside primary care.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    Across 2025/26, overall QOF achievement for England was 92.5%. Across practices, overall achievement ranged from 75.9% at High Glades Medical Centre to 98.7% at South Saxon House Surgery. In the vaccination and immunisation domain, achievement spanned 73.1 pp, from 15.6% at The Station Practice to 88.8% at South Saxon House Surgery, compared to England at 55.2%.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Priory Road10877.274.6%69.8%88.7%
    Carisbrooke12253.169.2%83.8%86.6%
    South Saxon House12441.475.2%57.6%84.4%
    Sedlescombe House10638.589.8%61.6%84.2%
    High Glades10639.648.4%55.7%76.5%
    Station10461.126.7%70.9%67.3%
    The Hill Surgery12726.227.7%67.3%62.5%
    Hastings Old Town10358.712.8%60.8%61.3%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNHastingsAssetPCNHastings
    Care homes (catchment)65 (1,541 beds)n/aSchools (catchment)76n/a
    Children's centres44Places of worship6251
    Libraries33Food banks (VCS)11
    Homelessness support (VCS)0no dataDay centres (VCS)55
    Children and young people (VCS)11Carers support groups (VCS)11
    Primary schools (LA maintained)52Primary academies1414

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review and recall

    Asthma reviews fell 4.3% (2.7 pp) over 2023 to 2025 to 60.2% (England 65.7%, +4.4%), leaving 2,611 (about 2,600) of 6,554 patients unreviewed; ages 6-19 second-hand smoke recording is 69.3% (England 78.8%). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Combined SMI physical health checks

    Across 1,684 SMI register patients (1.7% vs England 1.0%), annual BP checks are 80.4% (England 83.4%; +1.4 pp vs +4.4 pp, 2023 to 2025) and BMI recording is 78.0% (England 82.1%; +0.2 pp vs +5.1 pp). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Older hypertension and lipid recall

    On the 17,634 hypertension register (17.4% vs England 15.2%), 80+ BP control is 77.1% (England 81.2%; +0.9% vs +2.2%, 2023 to 2025), and QRISK ≥ 20% lipid therapy is 60.2% (England 63.6%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult service alignment (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall audit (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Older hypertensive blood pressure review (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Childhood immunisation call-recall audit (p6)MMR dose 1 coverage at 24 months10YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Structured asthma review and recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Combined SMI physical health checks (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Option 3 · Older hypertension and lipid recall (p12)Hypertension register · Hypertension: QOF prevalence · Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15